Mirion Technologies, Inc. (MIR)

11.09 +0.08 (+0.73%) At close: 04:00PM EDT

Mirion Technologies, Inc.

1218 Menlo Drive
Atlanta, GA 30318
United States
770 432 2744
https://www.mirion.com

Sector(s): Industrials
Industry: Specialty Industrial Machinery
Full-time employees: 3,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Thomas D. Logan	Founder, Medical Group President, CEO & Director	1.87M	N/A	1961
Mr. Brian Schopfer	Chief Financial Officer	1.14M	N/A	1985
Mr. Loic Eloy	Group President of Technologies	626.84k	N/A	1977
Mr. Christopher Moore CPA	Chief Accounting Officer & Principal Accounting Officer	N/A	N/A	1972
Mr. James Cocks	Chief Technology Officer	N/A	N/A	N/A
Mr. Alex Gaddy	SVP of Strategy, IR & Treasurer	N/A	N/A	N/A
Ms. Emmanuelle Lee	Executive VP, General Counsel, Secretary & Chief Legal Officer	N/A	N/A	N/A
Erin Schesny	Chief Marketing Officer	N/A	N/A	N/A
Mr. Bertrand Duban	President of Nuclear Medicine	N/A	N/A	N/A
Ms. Shelia Webb	Chief Digital Officer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Corporate governance

Mirion Technologies, Inc.’s ISS governance QualityScore as of 1 April 2024 is 6. The pillar scores are Audit: 8; Board: 5; Shareholder rights: 6; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.